Vertex Pharmaceuticals Incorporated

04/28/2021 | Press release | Distributed by Public on 04/28/2021 05:34

Vertex Announces European Commission Approval for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat Cystic Fibrosis Patients 12 Years and Older[...]